Literature DB >> 12709770

Preoperative nested reverse transcription-polymerase chain reaction for prostate specific membrane antigen predicts non-organ confined disease in radical prostatectomy specimens.

John Varkarakis1, Charalambos Deliveliotis, Diamandis Sideris, Nikolaos Trakas, Aris Giannopoulos.   

Abstract

The aim of this study was to access the utility of the reverse transcriptase-polymerase chain reaction (RT-PCR) assay for prostatic specific membrane antigen (PSMA) in predicting non-organ confined (NOC) disease in final radical prostatectomy (RP) specimens. Nested RT-PCR for PSMA was performed on the blood of 33 patient candidates for RP, 20 patients with untreated metastatic disease and 20 healthy men. The final pathology report on the 33 RP patients was compared with the RT-PCR results and Partin nomograms. In the RP group, 4/18 patients with confined disease and 9/15 with NOC disease had positive RT-PCR assays. Sensitivity, specificity, positive and negative predictive values for RT-PCR were 60%, 77.7%, 69% and 70%, respectively. The Partin tables for this group of patients showed a sensitivity, specificity, positive and negative predictive values of 75%, 71%, 60% and 83%, respectively. P-values for the Partin tables and the RT-PCR assay were respectively 0.014 and 0.037. RT-PCR of PSMA has an independent predictive value and could help predict NOC disease in clinically localized prostate cancers, but is still less efficient than Partin tables.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12709770     DOI: 10.1007/s00240-003-0313-6

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  30 in total

1.  Detection of PSA mRNA in blood by RT-PCR does not exclusively indicate prostatic tumor cells.

Authors:  W Henke; M Jung; K Jung; M Lein; H Schlechte; C Berndt; B Rudolph; D Schnorr; S A Loening
Journal:  Clin Chem       Date:  1996-09       Impact factor: 8.327

2.  Prostate specific membrane antigen (PSM) is expressed in various human tissues: implication for the use of PSM reverse transcription polymerase chain reaction to detect hematogenous prostate cancer spread.

Authors:  H Renneberg; A Friedetzky; L Konrad; R Kurek; K Weingärtner; G Wennemuth; U W Tunn; G Aumüller
Journal:  Urol Res       Date:  1999

3.  Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.

Authors:  A Zippelius; P Kufer; G Honold; M W Köllermann; R Oberneder; G Schlimok; G Riethmüller; K Pantel
Journal:  J Clin Oncol       Date:  1997-07       Impact factor: 44.544

4.  Quantitative polymerase chain reaction does not improve preoperative prostate cancer staging: a clinicopathological molecular analysis of 121 patients.

Authors:  M H Sokoloff; C L Tso; R Kaboo; S Nelson; J Ko; F Dorey; R A Figlin; S Pang; J deKernion; A Belldegrun
Journal:  J Urol       Date:  1996-11       Impact factor: 7.450

5.  Circulating prostate-specific antigen mRNA during radical prostatectomy in patients with localized prostate cancer: with special reference to neoadjuvant hormonal therapy.

Authors:  O Ogawa; M Iinuma; K Sato; R Sasaki; N Shimoda; S Satoh; T Kato
Journal:  Urol Res       Date:  1999-08

Review 6.  Prostate-specific membrane antigen: current and future utility.

Authors:  A K Gregorakis; E H Holmes; G P Murphy
Journal:  Semin Urol Oncol       Date:  1998-02

7.  Prostate specific antigen reverse transcriptase-polymerase chain reaction assay in preoperative staging of prostate cancer.

Authors:  J M Ignatoff; M G Oefelein; W Watkin; J S Chmiel; K L Kaul
Journal:  J Urol       Date:  1997-11       Impact factor: 7.450

8.  Detection and clearance of prostate cells subsequent to ultrasound-guided needle biopsy as determined by multiplex nested reverse transcription polymerase chain reaction assay.

Authors:  D K Price; D R Clontz; W L Woodard; J S Kaufman; J M Daniels; S J Stolzenberg; C M Teigland
Journal:  Urology       Date:  1998-08       Impact factor: 2.649

9.  Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

Authors:  S W Melchior; E Corey; W J Ellis; A A Ross; T J Layton; M M Oswin; P H Lange; R L Vessella
Journal:  Clin Cancer Res       Date:  1997-02       Impact factor: 12.531

10.  Combined nested reverse transcription-PCR assay for prostate-specific antigen and prostate-specific membrane antigen in detecting circulating prostatic cells.

Authors:  Y Zhang; C D Zippe; F Van Lente; E A Klein; M K Gupta
Journal:  Clin Cancer Res       Date:  1997-07       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.